Volume : 10, Issue : 12, December – 2023
Title:
AN OVERVIEW OF NURSES AND PHARMACIST ROLES IN MONITORING AND SAFETY HIGH ALERT MEDICATIONS USED INPATIENT
Authors :
Khaled Thawab Mohsen Alsobaie, Mohammed Abdullah Hamed Alhazmi,Omar Jurais Mohammed Alharbi,Ahmed Ali Alsaedi,Ibrahim Mohammad Alsadi,Saad Mansour Alhazmi,Mohammed Saad Alkhosify,Awad Hmoud Alnefaey
Abstract :
Medication errors (MEs) are unintended failures in the drug treatment process that can occur during prescription, dispensing, storing, preparation or administration of medications. High alert medications (HAMs) are defined as those medications that bear the highest risk of causing significant patient harm when used incorrectly, either due to their serious adverse events or to a narrow therapeutic window. Nurses are responsible for administration of HAMs; incorrect administration can have a significant clinical outcome. Nurses play a crucial role in the safety of medicines management during transitional care. Therefore, they should be empowered and more involved in medicines management initiatives in the healthcare system. Patient safety and avoidance of medication errors during transitional care require that medicines management becomes a multidisciplinary collaboration with effective communication between healthcare providers.
Cite This Article:
Please cite this article in press Khaled Thawab Mohsen Alsobaie et al., AN OVERVIEW OF NURSES AND PHARMACIST ROLES IN MONITORING AND SAFETY HIGH ALERT MEDICATIONS USED INPATIENT, Indo Am. J. P. Sci, 2023; 10 (12).
Number of Downloads : 10
References:
1. Haan J, Hollander J, Ferrari MD. Migraine in the elderly: a review. Cephalalgia. 2007 Feb;27(2):97-106.
2. Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010 May;30(5):599-609.
3. Arunachalam A, Karthikeyan M, Kumar SA, Konam K, Prasad PH, Sethuraman S, Manidipa S. Fast dissolving drug delivery system: a review. Journal of global trends in pharmaceutical sciences. 2010 Oct;1(1):92-110.
4. Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery system and dosage form. International Journal of ChemTech Research. 2010 Jan 1;2(1):576-83.
5. Dixit RP, Puthli SP, Oral strip technology: Overview and future potential, Journal of Control Release, 139, 2009, 94–107.
6. Estemalik E, Tepper S, Preventive treatment in migraine and the new US guidelines, Neuropsychiatr Dis Treat, 9, 2013, 709–720
7. Láinez MJ. Rizatriptan in the treatment of migraine. Neuropsychiatric Disease and Treatment. 2006 Sep 1;2(3):247-59.
8. Dahlof CG, Rapoport AM, Sheftell FD, Lines CR. Rizatriptan in the treatment of migraine. Clinical therapeutics. 1999 Nov 1;21(11):1823-36.
9. Panchal MS, Patel H, Bagada A, Vadalia KR. Formulation and evaluation of mouth dissolving film of ropinirole hydrochloride by using pullulan polymers. International Journal of Pharmaceutical Research & Allied Sciences. 2012;1(3):60-72.
10. Upreti K, Kumar L, Anand SP, Chawla V. Formulation and evaluation of mouth dissolving films of paracetamol. Int J Pharm Pharm Sci. 2014;6(5):200-2.
11. Pawar R, Sharma R, Sharma P, Darwhekar GN. A review on mouth dissolving film. Journal of Drug delivery and Therapeutics. 2019 Nov 15;9(6):206-10.
12. Kokare CK, Tagalpallewar AA, Aragade PS, Bagul US, Bacchav RK, Nanjwade BK. Formulation, evaluation and optimization of asenapine maleate fast mouth dissolving film. Journal of Pharmaceutical Sciences and Pharmacology. 2015 Sep 1;2(3):194-207.
13. Garsuch V, Breitkreutz J. Comparative investigations on different polymers for the preparation of fast-dissolving oral films. Journal of Pharmacy and Pharmacology. 2010 Apr;62(4):539-45.
14. Okamoto H, Taguchi H, Iida K, Danjo K. Development of polymer film dosage forms of lidocaine for buccal administration: I. Penetration rate and release rate. Journal of controlled release. 2001 Dec 13;77(3):253-60.